These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 845796)

  • 1. Stability of (pyrrolidone-5-hydroxamato)iron (III) chelates.
    Pećar M; Kujundzić N; Pazman J
    J Pharm Sci; 1977 Mar; 66(3):330-3. PubMed ID: 845796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous mixture of pyrrolidone-5-hydroxamic acid-iron (III) complexes: isolation and characterization of tris (pyrrolidone-5-hydroxamato) iron (III).
    Pećar M; Kujundzić N; Mlinarević B; Cerina D; Horvat B; Verić M
    J Pharm Sci; 1975 Jun; 64(6):970-3. PubMed ID: 1133753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reduction of hydroxamic acids with titanium(III) chloride: a tool for the characterization of siderophores.
    Kushner DJ; Landry TA; Tyrrell MC; Akers HA
    Anal Biochem; 1983 Aug; 133(1):116-9. PubMed ID: 6227259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the aqueous iron(III) chelation chemistry of a potential Trojan Horse antimicrobial agent: chelate structure, stability and pH dependent speciation.
    Harrington JM; Gootz T; Flanagan M; Lall M; O'Donnell J; Winton J; Mueller J; Crumbliss AL
    Biometals; 2012 Oct; 25(5):1023-36. PubMed ID: 22855208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of iron (III) chelates in oral treatment of anemia: solution properties and absorption of iron (III) acetohydroxamate in anemic rats.
    Brown DA; Chidambaram MV; Clarke JJ; McAleese DM
    Bioinorg Chem; 1978 Sep; 9(3):255-75. PubMed ID: 698284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamics, kinetics, and mechanism of the stepwise dissociation and formation of Tris(L-lysinehydroxamato)iron(III) in aqueous acid.
    Wirgau JI; Spasojević I; Boukhalfa H; Batinić-Haberle I; Crumbliss AL
    Inorg Chem; 2002 Mar; 41(6):1464-73. PubMed ID: 11896715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of cyanide with hydroxamic acid iron complexes to distinguish trihydroxamates from simple monohydroxamates.
    Emery T
    Anal Biochem; 1984 Jun; 139(2):301-4. PubMed ID: 6236709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revision of iron(III)-citrate speciation in aqueous solution. Voltammetric and spectrophotometric studies.
    Vukosav P; Mlakar M; Tomišić V
    Anal Chim Acta; 2012 Oct; 745():85-91. PubMed ID: 22938610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chelating agents related to ethylenediamine bis(2-hydroxyphenyl)acetic acid (EDDHA): synthesis, characterization, and equilibrium studies of the free ligands and their Mg2+, Ca2+, Cu2+, and Fe3+ chelates.
    Yunta F; García-Marco S; Lucena JJ; Gómez-Gallego M; Alcázar R; Sierra MA
    Inorg Chem; 2003 Aug; 42(17):5412-21. PubMed ID: 12924915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Octanhydroxamate of iron: synthesis, analysis and investigation of stability].
    Palma P; Sapragoniene M; Stankevicius A
    Medicina (Kaunas); 2003; 39 Suppl 2():55-9. PubMed ID: 14617860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Siderophores--the carriers of the iron ion].
    Chimiak A
    Postepy Biochem; 1984; 30(3-4):435-60. PubMed ID: 6242126
    [No Abstract]   [Full Text] [Related]  

  • 12. The determination of the stability constant for the iron(II) complex of the biochelator pyridine-2,6-bis(monothiocarboxylic acid).
    Brandon MS; Paszczynski AJ; Korus R; Crawford RL
    Biodegradation; 2003 Apr; 14(2):73-82. PubMed ID: 12877463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malonichrome, a new iron chelate from Fusarium roseum.
    Emery T
    Biochim Biophys Acta; 1980 May; 629(2):382-90. PubMed ID: 7388041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid dissociation and metal complex formation constants of penicillamine, cysteine, and antiarthritic gold complexes at simulated biological conditions.
    Zucconi TD; Janauer GE; Donahe S; Lewkowicz C
    J Pharm Sci; 1979 Apr; 68(4):426-32. PubMed ID: 438961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper complexation by 3-hydroxypyridin-4-one iron chelators: structural and iron competition studies.
    el-Jammal A; Howell PL; Turner MA; Li N; Templeton DM
    J Med Chem; 1994 Feb; 37(4):461-6. PubMed ID: 7509878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn(II), Ni(II), Cu(II) and Fe(III) complexes.
    Griffith DM; Szocs B; Keogh T; Suponitsky KY; Farkas E; Buglyó P; Marmion CJ
    J Inorg Biochem; 2011 Jun; 105(6):763-9. PubMed ID: 21496451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron chelation properties of an extracellular siderophore exochelin MN.
    Dhungana S; Miller MJ; Dong L; Ratledge C; Crumbliss AL
    J Am Chem Soc; 2003 Jun; 125(25):7654-63. PubMed ID: 12812507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron(III)-chelating properties of the novel catechol O-methyltransferase inhibitor entacapone in aqueous solution.
    Orama M; Tilus P; Taskinen J; Lotta T
    J Pharm Sci; 1997 Jul; 86(7):827-31. PubMed ID: 9232524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemistry of iron in biological systems.
    Neilands JB
    Adv Exp Med Biol; 1973; 40():13-42. PubMed ID: 4358681
    [No Abstract]   [Full Text] [Related]  

  • 20. Iron chelation properties of an extracellular siderophore exochelin MS.
    Dhungana S; Ratledge C; Crumbliss AL
    Inorg Chem; 2004 Oct; 43(20):6274-83. PubMed ID: 15446873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.